🏮Announcing the Lantern Summit in Shanghai🏮
In 2025, more new medicines launched first in China than anywhere else on Earth.
That has never happened before.
Drug development has two simultaneous accelerators:
• AI is collapsing design (weeks instead of years).
• China is collapsing development (physical iteration speed).
Here is why that matters, and what Western biotech is missing: 🧵
Last month in Shanghai, the inaugural Lantern Summit brought together 450+ people from 300+ organizations across China and the West, building at the frontiers of life sciences.
Thank you for being part of it! 🏮
Yujing Wang joins us at The Lantern Summit.
VP of Product & Marketing at @neuracle, whose NEO system is the world’s first invasive BCI approved for commercial use. Ex-Johns Hopkins neurology postdoc.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Yiying Wang joins us at The Lantern Summit.
Counsel in Cooley’s Shanghai office, advising companies, banks and PE funds on US and Hong Kong IPOs and cross-border licensing and M&A.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Dr. Wenshou Wang joins us at The Lantern Summit.Co-founder and COO of METiS TechBio.
Ex-MIT CSAIL research scientist and co-founder of AI 3D-printing company Inkbit. PhD, Chinese Academy of Sciences.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Dr. WeikangT ao joins us at The Lantern Summit.
Group VP and head of global innovative R&D at Qilu Pharmaceutical; ex-Hengrui R&D CEO and Merck. 90+ drug candidates into the clinic, 15 approved in China.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
@WeidiXie joins us at The Lantern Summit.
Associate Professor at SJTU’s School of AI and CEO of OneXIntelligence, working on multimodal AI for the life sciences. 25,000+ citations; Oxford DPhil.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Weian Zhao joins us at The Lantern Summit.
Founder & CEO of @AurekaBio Biotechnologies, digitalising drug discovery with generative AI and high-throughput biology. MIT TR35, NIH New Innovator Award.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Sherry Liu joins us at The Lantern Summit.
Director of the Healthcare Fund at Hony Capital, backing Fosun Kite, Excalipoint and SKYEMED. Previously CCB PE, Fosun and Flagship Pioneering.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Shaoqing Ni joins us at The Lantern Summit.
Chief Pharmacist at Zhejiang University Children’s Hospital, heading its clinical trial office. Leads national projects on paediatric drug improvement.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Chong Xu joins us at The Lantern Summit.
Partner at @FPrimeCapital and founding investor in AlphaGen Tx, Pediatrix, Skyline Tx, K36 Tx and RareStone Group. Board roles incl. Innovent, Adagene and Sironax.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Dr. Chouwen Zhu joins us at The Lantern Summit.
Leads the Shanghai Clinical Research and Trial Center. Gastroenterologist, clinical epidemiologist, former VP of Zhongshan Hospital, Fudan University.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163🏮
Kenneth Sun joins us at The Lantern Summit.
Head of Asia at Royalty Pharma, leading its royalty business across the region. Previously Head of APAC Healthcare Investment Banking at Morgan Stanley.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Keats Shi joins us at The Lantern Summit.
CEO of Jiyu Bio, building an AI agent that matches foreign patients with treatments in China and biotechs with Chinese clinical resources. PhD, Baylor.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOptgv 🏮
Luyan Dai joins us at The Lantern Summit.
Runs clinical data governance at the GBA National Innovation Center. Founded Boehringer Ingelheim’s China statistics team; built Harbour BioMed’s clinical team.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Dr. Lipeng Lai joins us at The Lantern Summit.
Co-founder & Chief Innovation Officer of @XtalPi (https://t.co/TBJ1IbsyWa). Now co-founding INFevo, an AI virtual cell built on biological foundation models.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮
Derek Weng joins us at The Lantern Summit.
CEO of Blueprint China, Bryan Johnson’s longevity brand. Founder & CEO of Lemonbox, personalised nutrition for 10M+ users. YC alum, ex-Walmart Labs.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163
Andrew Bartynski joins us at The Lantern Summit.
Co-founder & CEO of Kopra Bio, building viral vectors that reprogram solid tumors. His last company went from founding to Phase II/III in six months.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163🏮
@WoodingtonBen joins us at The Lantern Summit.
Founder & CEO of Coherence Neuro, using neural interfaces to treat, track and model cancer. Clinical stage. PhD from Cambridge’s Bioelectronics Lab.
Shanghai · 26–27 Oct 2026
https://t.co/DezTcOq163 🏮